This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
Rightmove PLC | 654.0 | 4.3% |
Spirax Group PLC | 6,925.0 | 4.2% |
Experian PLC | 3,647.0 | 3.7% |
Games Workshop Group PLC | 13,170.0 | 2.9% |
Hiscox LTD | 1,077.0 | 2.8% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
Jd Sports Fashion PLC | 87.4 | -5.9% |
Taylor Wimpey PLC | 111.1 | -2.9% |
Whitbread PLC | 2901.0 | -2.4% |
Easyjet PLC | 497.5 | -1.7% |
Pershing Square Holdings LTD | 4202.0 | -1.5% |
Major World Indices | Price | % Chg | 1 Year |
UK 100 INDEX | 8,392 | 1.1% | 12.7% |
DOW JONES INDUS. AVG | 43,153 | -0.2% | 15.8% |
DAX INDEX | 20,655 | 0.4% | 25.7% |
NIKKEI 225 | 38,451 | -0.3% | 8.4% |
S&P/ASX 200 INDEX | 8,310 | -0.2% | 12.4% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 79.09 | 0.52% |
Brent Crude (ICE) | USD/bbl. | 81.52 | 0.28% |
Gold Spot | USD/t oz. | 2,713 | -0.1% |
Copper (Comex) | USd/lb. | 446 | 0.4% |
The UK 100 called to open +72 points at 8,464. The UK 100 looks set to open higher once again this morning,
Asian markets were mixed on Friday after indexes in the US. on Thursday drifted lower following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies. Japan’s Nikkei index lost 0.56% to 38,36, marking their lowest levels in at least a month. The Shanghai Composite gained 0.40% to 3,249, as mainland stocks struggled to find clear direction as investors reacted to the latest economic data. Hong Kong’s Hang Seng index advanced 0.17% to 19,556, up for the fourth day as traders reacted to fresh data from the mainland.
China reported its economy grew 5% in 2024, meeting its target of around 5%. Analysts polled by Reuters had expected China’s full-year GDP growth to come in at 4.9%, just shy of the official target of around 5% — which analysts had said was ambitious. China’s economy grew 5.4% in the fourth quarter from a year ago — better than the 5% analysts had expected.
The S&P slipped Thursday, ending a three-day winning streak, as big tech shares pulled back. The broad market index slid 0.21% to 5,937.34. The tech-heavy Nasdaq dropped 0.89% to 19,338.29. The Dow Jones fell 68.42 points, or 0.16%, to 43,153.13. Apple shares were down 4%, posting their worst day since Aug. 5. Tesla tumbled more than 3%. Nvidia slid nearly 2%, and Alphabet lost around 1%.
AstraZeneca this morning said Calquence plus chemoimmunotherapy had been approved in the US for patients with previously untreated mantle cell lymphoma.
Evoke this morning delivered a reading update to the market, they said they have seen a strong performance in Q4 with Group revenue growth of approximately 12-13% year-over-year (c.13-14% in constant currency). This performance was driven by online growth of approximately 16-17% (c.18-19% in constant currency) with a continued improvement in the growth rate across Core Markets, all underpinned by the successful implementation of the Group’s strategy, and supported by operator friendly sports results during Q4. As a result, revenue growth in H2 is expected to be approximately 8%, towards the higher end of the previously communicated 5-9% guidance. Strong cost control and an increasingly efficient operating model mean that adjusted EBITDA is expected to be at the high end of the previously communicated guidance range of £300-310m for the full year, and well ahead of market expectations.
No New Broker Comments
UK
Ninety One
Petershill Partners
Safestore Holdings
US
SLB
UK
None
US
None
Chinese Gross Domestic Product
Chinese Industrial Production
Chinese Retail Sales
UK Retail Sales
EU Core Harmonized Index of Consumer Prices
US Industrial Production
UK 100 companies going ex-dividend on 23rd January 2025:
Games Workshop Group
UK 250 companies going ex-dividend on 23rd January 2025:
Foresight Solar Fund
Victrex
City of London Investment Trust
NB Private Equity Partners
Bankers Investment Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.